FDA Inspection 1006754 — Willsie, Sandra K
The FDA completed an inspection of Willsie, Sandra K on April 5, 2017 in Lenexa, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lenexa, KS (United States)
Additional Details
Clinical Investigator (CI)